The Business, Entrepreneurship & Tax Law Review


John Marshall


As the market for pharmaceutical drugs has grown, pharmacy benefit managers (“PBMs”) have been able to carve out a niche market for themselves and have become extremely profitable. However, their ability to regulate medication prices may be compromised through mergers with other entities involved in the complex pharmaceutical market. As illustrated by the CVS and Aetna merger, it is clear that a more effective regulatory body must step in or be formed to ensure that private companies cannot exploit. individuals who rely on these life-saving drugs.

First Page


Included in

Law Commons



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.